Coherent Fell Hard Over 3 Months: It Will Nearly Double According to These Analysts

Coherent (NYSE:COHR | COHR Price Prediction) trades at $268.64, while Wall Street’s average 12-month price target sits at $416.09. That gap implies roughly 55% upside, and the Street-high call from Rosenblatt Securities at $500 takes the potential move closer to doubling.

Coherent is the pure-play photonics vendor supplying the lasers, transceivers, and optical subsystems that stitch together AI datacenters. Its Datacenter & Communications segment produced 79% of last quarter’s revenue and grew 59% year over year. Coherent also joined the S&P 500 this year, adding a passive-flow tailwind to an already crowded bull story.

None of that stopped the stock from cratering over the summer, which is why the dislocation now looks so extreme. Coherent sits inside the broader AI infrastructure buildout, and we profiled seven of the picks-and-shovels suppliers powering that trade, from optics to cooling, in a free report you can grab here.

A 36% Three-Month Gut Punch on No Fundamental Break

Shares fell 35.64% over the past three months, sliding from $417.43 to current levels. That is a peer-leading drawdown, and it happened without a single crack in the operating story.

The catalysts were technical. Coherent completed a $2 billion common stock issuance that added supply pressure. AI-optical names had rallied violently into August, and profit-taking spread across the group. The Q4 earnings report on August 12 actually beat, with non-GAAP EPS of $1.74 versus the $1.6171 estimate and revenue of $2.045 billion up 33.74% year over year. The market still faded the earnings report, worried about capex intensity and the 87.45% collapse in full-year operating cash flow tied to $1.1 billion in capacity spending.

Rosenblatt’s $500 Call and Why the Sell Side Is Digging In

With upside to the average target now above 50% and Rosenblatt’s high call implying an 86% move, the bull thesis has become the centerpiece of the story. Rosenblatt lead analyst Mike Genovese lifted his target from $425 to $500, citing accelerating 800G and 1.6T transceiver shipments, Coherent’s vertical integration in six-inch indium phosphide wafers, and structural gross-margin expansion.

Management’s own commentary supports the aggressive math. CEO Jim Anderson told investors bookings extend into calendar 2028, long-term agreements run through the end of the decade, and Coherent has seen “absolutely no push out of CPO demand.” Management is targeting the first $3 billion revenue quarter by the end of fiscal 2027. Consensus EPS estimates for fiscal 2027 have been revised up from $8.0885 to $9.4061 over the past 90 days.

Of Coherent’s 23 covering analysts, 4 rate the stock Strong Buy, 14 Buy, and 5 Hold, with no Sell ratings. Recent activity has been dominated by upward revisions, not downgrades. Targets remain projections, and the direction of travel is one-sided.

Photonics Peers Tell a Split-Screen Story

The AI-optical group did not sell off in unison. Coherent’s peers actually held up, which frames its 35% drawdown as a name-specific reset.

Lumentum Holdings (NASDAQ:LITE) has ripped 136.19% year to date to $870.58. Its analyst target of $1148.30 implies about 32% upside, and the ratings tilt heavily bullish across 26 covering analysts. Wall Street sees less headroom here than at Coherent.

Fabrinet (NYSE:FN) is the outlier, down 13.16% YTD at $395.35 despite a blowout fiscal Q4. Its $734.11 target implies roughly 86% upside, the largest in the group and effectively tied with Coherent’s Rosenblatt call.

Ciena (NYSE:CIEN) trades at $354.16 with a $557.29 target and about 57% implied upside, roughly matching Coherent’s average-target gap. Ratings are more mixed, with one Strong Sell in the mix.

Fabrinet holds the largest analyst-implied upside in the peer group, but Coherent’s setup is uniquely attractive: comparable upside to Ciena on average, and the biggest post-selloff reset of the four.

Coherent’s Data Points in Plain English

Coherent trades at $268.64 against a consensus 12-month target of $416.09, roughly 55% below where the average of 23 analysts thinks it should be. Rosenblatt’s Street-high $500 puts the ceiling near 86% above spot.

Despite the recent damage, COHR is still up 45.55% year to date, well ahead of the S&P 500’s 12.21% gain. The one-year return sits at 205.97%. Forward P/E is 27x against a fiscal 2027 consensus EPS of $9.4061.

Where I Actually Land on Coherent Here

The bull case firms up if the indium phosphide ramp lands on schedule, CPO revenue begins contributing in the December quarter as guided, and gross margin clears the 42% target model. That combination unlocks the fiscal 2028 EPS of $13.9489 Street consensus is now underwriting, and $416 becomes a reasonable print. The thesis weakens if capex intensity keeps operating cash flow depressed, hyperscaler order timing wobbles, or CPO adoption slips into late 2027.

My lean is bullish. The selloff looks like supply-driven digestion after a 200% run, with the demand story intact, and management’s backlog visibility is the deepest it has been. The Rosenblatt double reads as an upside scenario, and 55% to the average target with a booked-out fiscal 2027 is a setup worth owning.

Contact [email protected] for any questions or corrections.